Donate

The cost of life

© Olivier Papegnies
Faced with significant price increases for new drugs, in North and South alike, particularly drugs for cancer, hepatitis C and rare diseases, civil society in France is taking action to defend access to best-quality care for all, and to safeguard the public healthcare system. Several organisations...
Gilead’s price gouging for sofosbuvir blocks millions of people from getting treatment.
© Olivier Papegnies
Faced with significant price increases for new drugs, in North and South alike, particularly drugs for cancer, hepatitis C and rare diseases, civil society in France is taking action to defend access to best-quality care for all, and to safeguard the public healthcare system. Several organisations...
It is no secret that the price of medicines is getting higher and higher, and that these prices are absolutely unjustified. That pharmaceutical companies make huge and contemptable profit margins on treatments for sick people, that the National Health Service cannot maintain. When it comes to...
Les nouveaux médicaments antiviraux à action directe sont certes très efficaces, mais atteignent des prix inquiétants © Reuters
We are all entitled to know about the process involved in pricing a medicine. Let’s not let pharmaceutical laboratories decide on “the price to put on a life” using profitability as criteria.
Today in the UK , doctors have to tell patients that they could cure them using a specific medicine, but cannot prescribe it because it’s too expensive. To avoid the collapse of our health service, the British Government has established selection strategies to decide which patients can benefit from...
The Pharmaceutical Price Regulation Scheme (PPRS) is the mechanism used by the UK Department of Health to ensure that the NHS has access to good quality medicines at reasonable prices. It involves a non-contractual agreement between the UK Department of Health and The Association of the British...
© Olivier Papegnies
Doctors of the World has filed today a new patent opposition on Sofosbuvir. This patent is related to base compound that is used to produce the drug.